Home

Aarti Pharmalabs Ltd PE Ratio

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

PE

25.9

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Aarti Pharmalabs Ltd is 25.9 as of 15 Jan 11:27 AM .
  • The P/E Ratio of Aarti Pharmalabs Ltd changed from 12.9 on March 2023 to 18.2 on March 2024 . This represents a CAGR of 18.78% over 2 years.
  • The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 656.45 as of 15 Jan 11:20 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Aarti Pharmalabs Ltd

No data available

Company Fundamentals for Aarti Pharmalabs Ltd

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

Share Price

₹ 656.45

4.20 (0.64%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Aarti Pharmalabs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Pharmalabs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025652.25
13 Jan 2025659.95
10 Jan 2025669.05
09 Jan 2025658.95
08 Jan 2025657.3
07 Jan 2025667.15
06 Jan 2025647.55
03 Jan 2025671.05
02 Jan 2025691.95
01 Jan 2025699.5

SWOT Analysis Of Aarti Pharmalabs Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Aarti Pharmalabs Ltd

Asset Value vs Market Value of Aarti Pharmalabs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Aarti Pharmalabs Ltd5911
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Aarti Pharmalabs Ltd Explained

``

5911

Market cap

228

Earnings

25.9X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Aarti Pharmalabs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Aarti Pharmalabs Ltd

No data available

* All values are in %

About Aarti Pharmalabs Ltd

  • Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019.
  • The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.
  • It expanded block for CSD, Vapi and API, Tarapur units in 2022. The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021.

Aarti Pharmalabs Ltd News Hub

Aarti Pharmalabs consolidated net profit rises 17.75% in the June 2024 quarter

Net profit of Aarti Pharmalabs rose 17.75% to Rs 55.45 crore in the quarter ended June 2024 as again

Read more

2024-08-05 00:00:00

Aarti Pharmalabs to discuss results

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 28 October 2024. Po

Read more

2024-10-22 00:00:00

Aarti Pharmalabs consolidated net profit rises 5.44% in the September 2024 quarter

Net profit of Aarti Pharmalabs rose 5.44% to Rs 54.62 crore in the quarter ended September 2024 as a

Read more

2024-10-28 00:00:00

Aarti Pharmalabs Company Secretary resigns

Aarti Pharmalabs has announced that Mr. Nikhil Natu has tendered his resignation from the position o

Read more

2024-10-28 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Aarti Pharmalabs Ltd

What is the current PE Ratio of Aarti Pharmalabs Ltd?

The Current PE Ratio of Aarti Pharmalabs Ltd is 25.91 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Aarti Pharmalabs Ltd last year?

The PE Ratio of Aarti Pharmalabs Ltd was 12.86 last year, now the PE ratio is 25.91, showing a year-on-year growth of 101.5%.

What does the PE Ratio of Aarti Pharmalabs Ltd indicate about its stock?

The PE Ratio of Aarti Pharmalabs Ltd is 25.91. This ratio indicates that investors are willing to pay 25.91 times the earnings per share for each share of Aarti Pharmalabs Ltd.

What is the PE Ratio Growth of Aarti Pharmalabs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Aarti Pharmalabs Ltd grew by 101.5% whereas, the EPS ratio grew by -1.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions